| Dr John Ramey, MD | |
|
7555 Northside Dr, North Charleston, SC 29420-4211 | |
| (843) 797-8162 | |
| (843) 820-1300 |
| Full Name | Dr John Ramey |
|---|---|
| Gender | Male |
| Speciality | Allergy/immunology |
| Experience | 24 Years |
| Location | 7555 Northside Dr, North Charleston, South Carolina |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1841260874 | NPI | - | NPPES |
| 57-1072039 | Other | SC | TAX IDENTIFICATION |
| 276800 | Medicaid | SC |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207K00000X | Allergy & Immunology | 20-27680 (South Carolina) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| National Allergy Asthma And Urticaria Centers Of Charleston, Pa | 4385653054 | 7 |
News Archive
Janssen R&D Ireland announced today an amendment to its existing agreement with Gilead Sciences, Inc., initially established in 2011, for the development of a once daily, darunavir-based, single-tablet regimen (STR) for the treatment of people living with HIV.
Almost three-quarters (74%) of American consumers surveyed would prefer a non-surgical procedure over liposuction even if it meant more treatments were needed.
BioInvent International AB has announced that it has entered into a licence and discovery agreement with DAIICHI SANKYO COMPANY, LIMITED for the development of therapeutic antibodies against multiple targets. Under the terms of the collaboration, Daiichi Sankyo will be granted broad access to BioInvent's discovery and development technology platform and in house antibody expertise. As part of the agreement, BioInvent has secured certain co-promotion rights in Scandinavia and the Baltic countries.
NeuroSearch today announced that further analysis of the data from the MermaiHD study with Huntexil(R) (pridopidine) for the treatment of Huntington's disease supports potential disease modifying properties of the drug.
› Verified 4 days ago
| Entity Name | National Allergy Asthma & Urticaria Centers Of Charleston, Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1023103850 PECOS PAC ID: 4385653054 Enrollment ID: O20060410000116 |
News Archive
Janssen R&D Ireland announced today an amendment to its existing agreement with Gilead Sciences, Inc., initially established in 2011, for the development of a once daily, darunavir-based, single-tablet regimen (STR) for the treatment of people living with HIV.
Almost three-quarters (74%) of American consumers surveyed would prefer a non-surgical procedure over liposuction even if it meant more treatments were needed.
BioInvent International AB has announced that it has entered into a licence and discovery agreement with DAIICHI SANKYO COMPANY, LIMITED for the development of therapeutic antibodies against multiple targets. Under the terms of the collaboration, Daiichi Sankyo will be granted broad access to BioInvent's discovery and development technology platform and in house antibody expertise. As part of the agreement, BioInvent has secured certain co-promotion rights in Scandinavia and the Baltic countries.
NeuroSearch today announced that further analysis of the data from the MermaiHD study with Huntexil(R) (pridopidine) for the treatment of Huntington's disease supports potential disease modifying properties of the drug.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr John Ramey, MD 7555 Northside Dr, North Charleston, SC 29420-4211 Ph: (843) 797-8162 | Dr John Ramey, MD 7555 Northside Dr, North Charleston, SC 29420-4211 Ph: (843) 797-8162 |
News Archive
Janssen R&D Ireland announced today an amendment to its existing agreement with Gilead Sciences, Inc., initially established in 2011, for the development of a once daily, darunavir-based, single-tablet regimen (STR) for the treatment of people living with HIV.
Almost three-quarters (74%) of American consumers surveyed would prefer a non-surgical procedure over liposuction even if it meant more treatments were needed.
BioInvent International AB has announced that it has entered into a licence and discovery agreement with DAIICHI SANKYO COMPANY, LIMITED for the development of therapeutic antibodies against multiple targets. Under the terms of the collaboration, Daiichi Sankyo will be granted broad access to BioInvent's discovery and development technology platform and in house antibody expertise. As part of the agreement, BioInvent has secured certain co-promotion rights in Scandinavia and the Baltic countries.
NeuroSearch today announced that further analysis of the data from the MermaiHD study with Huntexil(R) (pridopidine) for the treatment of Huntington's disease supports potential disease modifying properties of the drug.
› Verified 4 days ago
Dr. Patricia S Gerber, M.D. Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 7555 Northside Dr, North Charleston, SC 29420 Phone: 843-797-8162 Fax: 843-820-1300 | |
Dr. Allen P Kaplan, M.D.M.D. Allergy & Immunology Medicare: Not Enrolled in Medicare Practice Location: 9165 University Blvd, North Charleston, SC 29406 Phone: 843-797-8162 Fax: 843-820-1300 | |
Dr. Albert F Finn, M.D. Allergy & Immunology Medicare: Not Enrolled in Medicare Practice Location: 9165 University Blvd, North Charleston, SC 29406 Phone: 843-797-8162 Fax: 843-820-1300 | |
Dr. Frederick M Schaffer, M.D. Allergy & Immunology Medicare: Not Enrolled in Medicare Practice Location: 9165 University Blvd, North Charleston, SC 29406 Phone: 843-797-8162 Fax: 843-820-1300 | |
Dr. Arthur M Labruce, M.D, Allergy & Immunology Medicare: Not Enrolled in Medicare Practice Location: 9231 Medical Plaza Dr, Suite E, North Charleston, SC 29406 Phone: 843-572-1771 Fax: 843-572-8962 | |
Dr. Ned T Rupp, M.D. Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 7555 Northside Dr, North Charleston, SC 29420 Phone: 843-797-8162 Fax: 843-820-1300 |